• Home
  • Product Catalog
    • Fixed Income
      • Multi-Sector Fixed Income Strategy
        • Multi-Sector Fixed Income Fund
      • Multi-Asset Credit Strategy
        • Multi-Asset Credit Fund
      • Systematic Investment Grade Credit Strategy
        • Systematic Investment Grade Credit ETF
      • U.S. Treasury Strategy
        • U.S. Treasury Fund
      • High Yield Strategy
        • High Yield Fund
      • Emerging Country Local Debt Strategy
        • Emerging Country Local Debt Investment Fund
      • Emerging Country Debt Strategy
        • Emerging Country Debt Shares Fund
        • Emerging Country Debt UCITS Fund
        • Emerging Country Debt Fund
        • Emerging Country Debt Investment Fund
      • Opportunistic Income Strategy
        • Opportunistic Income Fund
    • Equities
      • Beyond China Strategy
        • Beyond China ETF
      • International Quality Strategy
        • International Quality ETF
      • Small Cap Quality Strategy
        • Small Cap Quality Fund
      • Horizons Strategy
        • Horizons Investment Fund
      • U.S. Quality Strategy
        • U.S. Quality Investment Fund
        • U.S. Quality ETF
      • International Opportunistic Value Strategy
        • International Value ETF
        • International Opportunistic Value Fund
      • Resource Transition Strategy
        • Resource Transition Fund
      • U.S. Opportunistic Value Strategy
        • U.S. Value ETF
        • U.S. Opportunistic Value Fund
      • Small Cap Quality Strategy
      • Emerging Markets ex-China Strategy
        • Emerging Markets ex-China Fund
      • Usonian Japan Value Creation Strategy
        • Usonian Japan Value Creation Investment Fund
        • Usonian Japan Value Creation Fund
      • Usonian Japan Value Strategy
      • U.S. Small Cap Value Strategy
        • U.S. Small Cap Value Fund
      • U.S. Equity Strategy
        • U.S. Equity Fund
      • International Equity Strategy
        • International Equity Fund
      • International Developed Equity Allocation Strategy
        • International Developed Equity Allocation Fund
      • International All Country Equity Allocation Strategy
        • International Equity Allocation Fund
      • Resources Strategy
        • Resources UCITS Fund
        • Resources Fund
      • Quality Strategy
        • Quality Select Investment Fund
        • Quality Trust
        • Quality Fund
        • Quality Investment Fund
      • Global Developed Equity Allocation Strategy
        • Global Developed Equity Allocation Fund
      • Global All Country Equity Allocation Strategy
        • Global Equity Allocation Fund
        • Global Equity Allocation Investment Fund
      • Climate Change Strategy
        • Climate Change Select Transition Investment Fund
        • Climate Change Trust
        • Climate Change Fund
        • Climate Change Transition Investment Fund
      • Emerging Markets Equity Strategy
        • Emerging Markets Collective Investment Trust
        • Emerging Markets Trust
        • Emerging Markets Fund
        • Emerging Markets Equity Fund
      • Emerging Markets Select Equity Strategy
        • Emerging Markets Select Equity Fund
        • Emerging Domestic Opportunities Equity Fund
    • Alternatives
      • Equity Dislocation Strategy
        • Equity Dislocation Investment Fund
        • Equity Dislocation Fund
      • Quality Spectrum Strategy
        • Quality Spectrum Fund
      • Alternative Allocation Strategy
        • Alternative Allocation Fund
      • Risk Premium Strategy
      • Systematic Global Macro Strategy
        • Systematic Global Macro Trust
        • Systematic Global Macro Fund
        • Systematic Global Macro Fund
      • Event-Driven Strategy
        • Event-Driven Fund
    • Multi-Asset Class
      • Real Return Global Balanced Asset Allocation Strategy
      • Global Asset Allocation Strategy
        • Multi-Asset Trust
        • Global Asset Allocation Fund
      • Global Allocation Absolute Return Strategy
      • Benchmark-Free Allocation Strategy
        • Global Real Return (UCITS) Fund
        • Benchmark-Free Allocation Fund
  • Research Library
    • 2025
      • 05
        • 06
          • Update on Toyota Industries Corporation
      • 04
        • 24
          • Valuation Metrics in Emerging Debt: 1Q25
        • 15
          • GMO Asset Allocation's Big Bets
        • 11
          • GMO 7-Year Asset Class Forecast: 1Q 2025
        • 01
          • Tariffs: Making the U.S. Exceptional, but Not in a Good Way
      • 03
        • 25
          • Don’t Blame the Middleman
        • 24
          • Tariffs, Trade, and Trump
        • 17
          • GMO 7-Year Asset Class Forecast: February 2025
        • 13
          • Trade: The Most Beautiful Word in the Dictionary
        • 11
          • Three Reasons we’re Overweight Japanese Equities
        • 06
          • Rising Toxicity and the Threat to Capitalism and Life Itself
        • 05
          • A High-Quality Moment in High Yield
      • 02
        • 27
          • International Quality
        • 18
          • GMO 7-Year Asset Class Forecast: January 2025
        • 14
          • 2024 Year-End Letter: Quality Strategy
        • 13
          • Beyond China
        • 07
          • Three Reasons to Consider Dedicated Emerging Market Debt Exposure
      • 01
        • 24
          • Valuation Metrics in Emerging Debt: 4Q24
        • 17
          • GMO 7-Year Asset Class Forecast: 4Q 2024
        • 16
          • 2025 GMO Outlook
    • 2024
      • 12
        • 19
          • Bargain, Value Trap or Something in Between?
        • 17
          • Quality and Deep Value
        • 13
          • GMO 7-Year Asset Class Forecast: November 2024
        • 10
          • The Future of the Inflation Reduction Act
      • 11
        • 27
          • Inversiones Latin America Power Default
        • 15
          • GMO 7-Year Asset Class Forecast: October 2024
        • 08
          • 2024 GMO Conference
        • 05
          • Beyond the Factor
      • 10
        • 29
          • Quality: The Real McCoy
          • A Compelling Opportunity in Deep Value Stocks
        • 21
          • Tackling Indirect Emissions to Reach Net-Zero Targets
          • Employing Green Revenues in the Pursuit of Net-Zero Objectives
        • 18
          • GMO 7-Year Asset Class Forecast: 3Q 2024
        • 17
          • GMO Multi-Asset Credit
        • 16
          • Valuation Metrics in Emerging Debt: 3Q24
        • 10
          • Misguided Mayhem
      • 09
        • 26
          • A Second Opinion Is Just What the Doctor Ordered
        • 19
          • The What-Why-When-How Guide to Owning Emerging Debt_30th Anniversary Edition
        • 18
        • 17
          • John Pease on the Thoughtful Money Podcast
        • 03
          • Small Wonders
      • 08
        • 22
          • Jeremy Grantham on We Study Billionaires Podcast
        • 21
          • Deep Value
        • 15
      • 07
        • 31
          • Concentrate!
        • 19
          • Valuation Metrics in Emerging Debt: 2Q24
        • 17
          • A Second Opinion Is Just What The Doctor Ordered
          • GMO 7-Year Asset Class Forecast: 2Q 2024
        • 15
          • Explaining Strong Returns in the Face of Value Headwinds
        • 02
          • FAQ: Passive Investing
      • 06
        • 18
          • GMO 7-Year Asset Class Forecast: May 2024
        • 14
          • Tom Hancock on Masters in Business Podcast
          • Kim Mayer on Behind the Ticker Podcast
          • Tom Hancock on Exchange Traded Friday (ETF.com) Podcast
        • 12
          • The Quality Advantage in Small Cap Stocks
        • 04
          • Catherine LeGraw on the Meb Faber Podcast
          • Ben Inker on the Barron’s Live Podcast
      • 05
        • 20
          • GMO 7-Year Asset Class Forecast: April 2024
        • 08
          • Jeremy Grantham On The Insightful Investor Podcast
        • 02
          • Keep Calm and Carry On
      • 04
        • 26
          • Tina Vandersteel on the Meb Faber Show
        • 25
          • Timing Your Swing
        • 17
          • Valuation Metrics in Emerging Debt: 1Q24
        • 16
          • GMO 7-Year Asset Class Forecast: 1Q 2024
      • 03
        • 26
        • 25
          • Keys to Success and Longevity in Alternatives Management
        • 21
          • Record Highs…But We’re Still Excited
        • 20
          • GMO 7-Year Asset Class Forecast: February 2024
        • 18
          • Sustainability or Bust
        • 10
          • The Great Paradox of the U.S. Market!
        • 08
          • GMO Horizons
        • 04
          • Emerging Debt Energy Transition
          • GMO Equity Dislocation
      • 02
        • 20
          • GMO 7-Year Asset Class Forecast: January 2024
        • 15
          • Pollution, Population, and Purpose
        • 14
          • Usonian Letter Regarding Toyota
        • 13
          • A Structural Alpha Opportunity
        • 07
          • Magnificently Concentrated
      • 01
        • 23
          • Emerging Corporate Debt Fundamentals - How High Is the Risk?
          • The What-Why-When-How Guide to Owning Emerging Country Debt
        • 22
          • Valuation Metrics in Emerging Debt: 4Q23
        • 19
          • GMO 7-Year Asset Class Forecast: 4Q 2023
        • 18
          • 2024 GMO Outlook: Investors are Spoiled for Choice
        • 09
          • Emerging Local Debt
    • 2023
      • 12
        • 22
          • The Four 4s Behind the Compelling Opportunity in Japan Equities
        • 18
          • GMO 7-Year Asset Class Forecast: November 2023
        • 13
          • The Quality Anomaly
      • 11
        • 29
          • GMO 2023 Conference
        • 20
          • GMO 7-Year Asset Class Forecast: October 2023
        • 16
          • Quality: The Real McCoy
        • 02
          • GMO Quality for the Long Term and Today
      • 10
        • 31
          • Small Cap Quality
        • 19
          • Valuation Metrics in Emerging Debt: 3Q23
        • 17
          • Japan: The Land of the Rising Profits
        • 12
          • GMO 7-Year Asset Class Forecast: 3Q 2023
        • 04
          • Japan Equities Are Compelling…
        • 03
          • Argentina and Ecuador
      • 09
        • 28
          • Beyond the Landing
        • 20
          • It’s Quality…But Not As You Know It
        • 18
        • 17
          • Turbulence on the Path to Transformation
        • 08
          • Japan: This Time Really is Different
      • 08
        • 30
          • Why Is There More Volatility in My Portfolio?
        • 23
          • Does Democracy Matter for Emerging Sovereign Debt?
        • 14
      • 07
        • 21
          • Valuation Metrics in Emerging Debt: 2Q 2023
        • 20
          • GMO 7-Year Asset Class Forecast: 2Q 2023
        • 19
          • Estimating Value Chain Emissions for Portfolio Construction
        • 12
          • The Value and Quality Opportunity
        • 11
          • Slow Burn Minsky Moments
      • 06
        • 30
          • Weighted Average Green Revenue (WAGR): Integrating climate solutions into portfolio construction
          • The Quality Spectrum
        • 22
          • Weighing the Risk of Sanctions in Emerging Debt
        • 16
          • Value vs. Growth – The Opportunity Today
        • 09
          • GMO 7-Year Asset Class Forecast: May 2023
          • Value Is More Resilient in a Recession Than You Think
        • 08
          • Jump in the Deep End
        • 01
          • Value Does Just Fine in Recessions
      • 05
        • 24
          • The Next Generation of Green and Sustainable Investing at GMO
        • 23
          • The Quality Spectrum
        • 16
          • GMO 7-Year Asset Class Forecast: April 2023
          • The Curious Incident of the Elevated Profit Margins
        • 09
          • EM Quality Local Currency Debt – Another Piece of the Puzzle
        • 01
          • Jeremy Grantham on Rosenberg Research
      • 04
        • 27
          • Agency MBS: Focus on Current Coupons
        • 17
          • Valuation Metrics in Emerging Debt: 1Q 2023
          • GMO 7-Year Asset Class Forecast: 1Q 2023
        • 11
          • AT1 Bonds
      • 03
        • 30
          • AAA CMBS: Loss-remote, liquid, and cheaper than IG
        • 22
          • A Deep Value Investment in Financials
          • Echoes of '08? Don't Bank on It
        • 16
          • GMO 7-Year Asset Class Forecast: February 2023
      • 02
        • 28
          • The Many Faces of Sovereign Default
        • 17
          • GMO 7-Year Asset Class Forecast: January 2023
        • 08
          • What Is Value? Methodology Matters
        • 05
          • Valuation Metrics in Emerging Debt: 4Q 2022
      • 01
        • 30
          • 4Q 2022 GMO Quarterly Letter
        • 23
          • After a Timeout, Back to the Meat Grinder!
          • Taking Advantage of a Downturn
        • 10
          • GMO 7-Year Asset Class Forecast: 4Q 2022
          • Memo to the Investment Committee: A Hidden Gem
        • 09
          • 2023 Value Outlook
    • 2022
      • 12
        • 20
          • GMO 7-Year Asset Class Forecast: November 2022
        • 08
          • EM Corporate Debt ESG Integration
      • 11
        • 16
          • Technology Innovation to Generate Alpha
          • Fixed Income Solutions in a New Landscape
          • Climate Change and Ways to Leverage ESG
          • Emerging Markets: Turbulent Times and a New World Order
          • Inflation, Rates, and Recession Risks
          • The U.S. Superbubble
          • Opportunities in Today’s Environment
          • GMO 2022 Fall Conference
        • 21
          • GMO 7-Year Asset Class Forecast: October 2022
        • 30
          • 3Q 2022 GMO Quarterly Letter
      • 10
        • 28
          • 3Q 2022 Market Commentary
        • 27
          • Quality Time in Small Cap
        • 25
          • Valuation Metrics in Emerging Debt: 3Q 2022
          • Quality for the Long Run
        • 17
          • GMO 7-Year Asset Class Forecast: 3Q 2022
        • 13
          • Investing for Retirement III: Understanding and Dealing with Sequence Risk
          • Sovereign Contingent Bonds
        • 06
          • Value vs. Growth: The Unwind Continues
        • 03
          • Growth Investing Ain’t about the Rates
      • 09
        • 26
          • 2Q 2022 GMO Quarterly Letter
        • 19
          • GMO 7-Year Asset Class Forecast: August 2022
        • 13
          • Market Reversal or Bear Rally? Jeremy Grantham’s Views on the Superbubble
        • 07
          • Investing For Retirement III: Understanding and Dealing with Sequence Risk
      • 08
        • 31
          • Entering the Superbubble’s Final Act
        • 24
          • Let’s Not Get Carried Away
        • 18
          • Emerging Countries Are More Resilient Than They Get Credit For
        • 16
          • GMO 7-Year Asset Class Forecast: July 2022
        • 02
          • Investing for Retirement II: Modelling Your Assets
      • 07
        • 27
          • Valuation Metrics in Emerging Debt: 2Q 2022
        • 25
          • Deploying Capital in a Bear Market
        • 18
          • 2Q 2022 Market Commentary
        • 15
          • GMO 7-Year Asset Class Forecast: 2Q 2022
        • 12
          • Investors Still Seem Too Comfortable
      • 06
        • 27
          • Investing for Retirement II: Modelling Your Assets
        • 23
          • Time to Jump Aboard the Value Train
        • 17
          • Update On The Bursting Bubble In Growth Stocks
        • 16
          • Inflation in Japan Should Be Cheered, Not Feared
        • 15
          • What Does 8% Yield Pay For?
        • 14
          • GMO 7-Year Asset Class Forecast: May 2022
      • 05
        • 31
          • No Stone Unturned
        • 27
        • 25
          • Jeremy Grantham on CNBC's "The Exchange"
        • 23
          • Growth Traps Snap Shut
        • 18
          • 1Q 2022 GMO Quarterly Letter
        • 12
          • GMO 7-Year Asset Class Forecast: April 2022
        • 09
          • Valuation Metrics in Emerging Debt: 1Q 2022
        • 05
          • The Good Thing About Climate Change: 5 Years On
      • 04
        • 19
          • GMO 7-Year Asset Class Forecast: 1Q 2022
        • 18
          • Navigating Dislocations in Global Credit
        • 13
          • The Turn In Value Is Just Getting Started
        • 12
          • Watch Out for the Balance Sheet
        • 07
          • Time to Wake Up: Days of Abundant Resources and Falling Prices Are Over Forever
        • 06
          • Putin's Invasion Reminds Us That We Live in a Finite World
      • 03
        • 16
          • Deeply Discounted High Yield Index Products
        • 11
          • GMO 7-Year Asset Class Forecast: February 2022
      • 02
        • 28
          • A Focus on People and Purpose
        • 24
          • 4Q 2021 GMO Quarterly Letter
        • 23
        • 22
          • Making Money and Reducing Risk in an Equity Superbubble
        • 16
          • 4Q 2021 GMO Quarterly Letter_old
          • GMO 7-Year Asset Class Forecast: January 2022
        • 10
          • Valuation Metrics in Emerging Debt: 4Q 2021
        • 04
          • Valuation Disconnect
        • 02
          • 4Q 2021 Market Commentary
      • 01
        • 30
          • Equity Dislocation
        • 20
          • Let The Wild Rumpus Begin
        • 18
          • GMO 7-Year Asset Class Forecast: 4Q 2021
        • 09
          • Japan Equities: Entrenched Perceptions Ignore Improving Reality
    • 2021
      • 12
        • 21
          • GMO's Climate Change Strategy
          • Usonian Japan Value Strategy
          • GMO's Equity Dislocation Strategy
          • GMO's Emerging Markets Ex-China Strategy
        • 17
        • 14
          • 3Q 2021 GMO Quarterly Letter
        • 09
          • Value Traps vs. Growth Traps
        • 01
          • Valuation Metrics in Emerging Debt: 3Q 2021
      • 11
        • 22
          • 2021 GMO Conference
        • 17
        • 15
          • When Diversification Failed
          • Affirming the Case for Quality
          • My Sister's Pension Assets and Agency Problems
        • 10
          • More Than Meets the Eye
        • 03
          • 3Q 2021 Market Commentary
      • 10
        • 27
          • Wounds That Never Heal
        • 22
          • The Race of Our Lives
          • GMO 7-Year Asset Class Forecast: 3Q 2021
        • 15
          • Learning to Live with Covid-19
        • 12
          • Growth Bubble: Making Money on Companies That Make No Money
        • 07
          • LDI: The Bespoke Benefit
        • 06
          • China and Emerging Markets Ex-China
      • 09
        • 21
          • Part 2: What to Do in the Case of Sustained Inflation
      • 08
        • 31
          • 2Q 2021 GMO Quarterly Letter
        • 27
          • Merger Arbitrage Opportunity
        • 26
          • Resources Strategy
          • Emerging Markets Strategy
          • Quality Strategy
        • 24
        • 19
          • Equity Dislocation: Review
        • 18
          • Bubble Signs: Stock Issuance
        • 16
          • An Expensive Market Need Not Mean Expensive Stocks
        • 13
        • 12
          • Part 1: Inflation – Tall Tales and True Causes
          • Valuation Metrics in Emerging Debt: 2Q 2021
      • 07
        • 29
          • Japan Small Value
        • 23
          • 2021 Mid-Year Letter: Equity Allocation Strategies
          • 2021 Mid-Year Letter: Quality Strategy
        • 21
          • 2Q 2021 Market Commentary
        • 20
          • GMO 7-Year Asset Class Forecast: 2Q 2021
        • 19
          • It's Time to Pull the Alpha Lever
        • 12
          • Value vs. Growth Reversals
      • 06
        • 21
        • 15
          • Quality Investing and Inflation
        • 07
          • There Are No Bad Assets…Just Bad Prices
        • 04
          • GMO Climate Change Webcast
          • GMO Emerging Markets Webcast
          • GMO Quality Webcast
          • Profiting from a Bubble in Growth Stocks
        • 02
          • Resource Equities
      • 05
        • 18
          • 1Q 2021 GMO Quarterly Letter
          • Value's Turn: Eerie Parallels to 1999
        • 17
        • 07
          • Valuation Metrics in Emerging Debt: 1Q 2021
        • 05
        • 03
          • A Year of Investing in Quality Cyclicals
      • 04
        • 20
          • GMO 7-Year Asset Class Forecast: 1Q 2021
        • 15
          • Growth vs. Value: Mine the Gap
        • 11
          • Emerging Country Debt Capabilities
          • GMO Alternative Allocation Strategy
        • 07
          • China and EM ex-China
        • 06
          • The Competition for Corporate Control
      • 03
        • 31
          • Biofuels Poised to Make Major Impact
        • 23
          • The Duration of Value and Growth
        • 17
          • Japan Value: An Island of Potential in a Sea of Expensive Assets
        • 16
          • A SPAC-tacular Distraction
        • 05
          • Sovereign ESG Integration
      • 02
        • 26
          • Good News!
          • A Quality Strategy Update
        • 22
          • Chinese SOE Debt
        • 17
        • 04
          • Valuation Metrics in Emerging Debt: 4Q 2020
      • 01
        • 15
          • GMO 7-Year Asset Class Forecast: 4Q 2020
        • 03
          • Waiting for the Last Dance
    • 2020
      • 12
        • 18
        • 14
        • 07
          • 3Q 2020 GMO Quarterly Letter
      • 11
        • 25
          • Jeremy Grantham on CNBC's Closing Bell
        • 18
        • 09
          • Valuation Metrics in Emerging Debt: 3Q 2020
        • 05
          • Quality: The Real McCoy
        • 03
      • 10
        • 30
          • Covid-19, Climate Change, And The Need For A New Marshall Plan*
        • 15
      • 09
        • 22
          • 2Q 2010 GMO Quarterly Letter
        • 18
        • 14
          • No Complacency in Volatility
        • 10
          • The Mystery of SOE Debt
      • 08
        • 28
          • 2Q 2020 GMO Quarterly Letter
        • 27
          • The International Bank of Azerbaijan
        • 17
        • 14
          • Sovereign Contingent Bonds: How Emerging Countries Might Prepay for Debt Relief
        • 12
          • Reasons (NOT) To Be Cheerful
        • 04
          • Valuation Metrics in Emerging Debt: 2Q 2020
      • 07
        • 20
        • 09
          • Why We Are Not Worried About Elevated Profit Margins
        • 07
        • 06
          • Jeremy Grantham on CNBC's Closing Bell
      • 06
        • 22
        • 17
          • No Need to Bank on a Rebound
        • 03
          • 1Q 2020 GMO Quarterly Letter
        • 02
          • Alternative Allocation Strategy: 1-Year Anniversary
      • 05
        • 19
        • 13
        • 07
          • Hyperinflations, Hysteria, and False Memories
        • 05
          • Valuation Metrics in Emerging Debt: 1Q 2020
      • 04
        • 30
          • Climate Change Strategy: Divestment and Opportunities
          • The Race of Our Lives Revisited: Video
          • An Investment Only a Mother Could Love: The Tactical Case
        • 21
          • Top-Down Investing in Emerging Market Equities
        • 17
        • 16
        • 15
        • 08
          • It’s Always Darkest Before the Dawn
      • 03
        • 27
        • 25
          • Fear and the Psychology of Bear Markets
        • 23
        • 17
        • 16
        • 13
          • Dare to Be Different
        • 12
          • China’s Inclusion in the GBI-EMGD Benchmark: Beta and Alpha Implications
      • 02
        • 25
          • 60/40 Portfolios Face Double Trouble Ahead
        • 18
        • 14
        • 10
          • Valuation Metrics in Emerging Debt: 4Q 2019
        • 06
          • Chemical Toxicity and the Baby Bust
      • 01
        • 30
          • How Higher Ratings Are Changing Emerging Debt
        • 28
        • 15
    • 2019
      • 12
        • 17
      • 11
        • 20
          • Health Insurance Companies: Rhetoric vs. Reality
        • 18
        • 04
        • 01
          • Valuation Metrics in Emerging Debt: 3Q 2019
      • 10
        • 29
          • Emerging Market Stocks: Getting Comfortable with the Uncomfortable
        • 17
        • 07
          • 3Q 2019 GMO Quarterly Letter
      • 09
        • 18
      • 08
        • 29
          • 2Q 2019 GMO Quarterly Letter
        • 26
        • 23
          • The World’s Dumbest Idea
        • 01
          • EM Illiquid Is Not the Same as EM Small Cap – And That’s a Good Thing!
      • 07
        • 30
          • Risk and Premium: A Tale of Value
        • 24
          • Valuation Metrics in Emerging Debt: 2Q 2019
        • 17
          • Gaming Out Sovereign Default When China Is a Major Creditor
        • 08
          • Alphabet and the DOJ
      • 06
        • 12
      • 05
        • 15
          • Value Investing: Bruised by 1000 Cuts
        • 07
          • 1Q 2019 GMO Quarterly Letter
      • 04
        • 26
          • Valuation Metrics in Emerging Debt: 1Q 2019
        • 15
          • Thinking Outside the Box: How and Why to Invest in a Climate Change Strategy
        • 03
          • Why Does Everyone Hate MMT
      • 03
        • 18
          • Closing the Gulf: How The GCC Countries Fit Into Our Emerging Debt Investment Process
        • 11
          • Total Factor Productivity Growth
      • 02
        • 28
          • 4Q 2018 GMO Quarterly Letter
        • 26
          • Emerging Debt Valuation Update: 1Q17
          • Put Selling for Institutions
        • 24
          • It’s Everywhere, In Everything: The First Truly Global Bubble
          • Irrational Exuberance in the U.S. Equity Market
          • Is This Purgatory, Or Is It Hell?
          • No Silver Bullets in Investing
          • Back to Basics: Six Questions to Consider Before Investing
          • Emerging Consumers Just Want To Have Fun...
          • The Idolatry of Interest Rates, Part II: Financial Heresy and Potential Utility in an ERP Framework
          • The Idolatry of Interest Rates Part I
          • Investing for Retirement: The Defined Contribution Challenge
          • New Options for Equity Investors
          • The Seven Immutable Laws of Investing
          • I Want to Break Free, or, Strategic Asset Allocation Is Not Static Allocation
          • Reinvesting When Terrified
          • An Investment Only a Mother Could Love
          • Crisis and Opportunity in Emerging Market Debt
        • 23
          • Emerging Debt Valuation Update: 3Q18
          • Emerging Debt Valuation Update: 4Q18
          • Is the U.S. Stock Market Bubble Bursting?
          • Emerging Debt Valuation Update: 4Q17
          • Emerging Debt Valuation Update: 3Q17
          • Emerging Debt Valuation Update: 2Q17
        • 22
          • Treasury Inflation-Protected Securities – How Dry Is Your Powder?
          • FAANG SCHMAANG: Don't Blame the...
          • America is Great. Home Country Bias Ain’t.
          • Cash: One Investor’s Trash is Another Investor’s Treasure
          • Beware The Wu Wei of Passive Bond Investing
          • Whiplash: On Value, Growth, and Ignoring the Fundamentals
          • The What-Why-When-How Guide to Owning Emerging Country Debt
          • For Whom the Bond Tolls: Low Rate Beneficiaries in a Rising Rate Environment
          • The S&P 500: Just Say No
          • The Good Thing About Climate Change: Opportunities
          • Six Impossible Things Before Breakfast
          • The Deep Causes of Secular Stagnation...
          • I Do Indeed Believe the U.S. Market Will Revert Toward Its Old Means – Just Very Slowly
          • Don't Act Like Stalin!
          • What Happened to Inflation? And What Happens If It Comes Back?
          • Career Risk and Stalin’s Pension Fund: Investing in a World of Overpriced Assets
          • Emerging Value and Margin of Superiority
          • Why Are Stock Market Prices So High?
          • This Time Seems Very, Very Different
          • Up At Night
        • 20
          • The Late Cycle Lament: The Dual Economy, Minsky Moments, and Other Concerns
        • 06
          • Emerging Debt in a Rising Interest Rate Environment
        • 05
          • Quality Equities: The Solution to Today's Equity Conundrum
    • 2018
      • 11
        • 28
          • Emerging Debt Valuation Update: 1Q18
          • Bracing Yourself for a Possible Near-Term Melt-Up
          • Emerging Debt Valuation Update: 2Q18
          • Is Investing Starting to Get Difficult Again? I Hope So
          • Emerging Markets - No Reward Without Risk
          • The Race of our Lives Revisited
          • The Race of our Lives Revisited (in a nutshell)
          • Go West, Young Investor…But Go Wisely
          • Multi-Asset Class Strategies: How Do I Use Thee?
          • The Advent of a Cynical Bubble
          • Trade Wars Are Bad
          • Emerging Corporate Debt Fundamentals - How High Is the Risk?
  • Investment Capabilities
    • Strategies
    • Funds
    • QIFs & Private Funds
    • ETFs
    • ETFs
  • People
    • Investment Teams
    • Firm Management
    • Relationship Team
    • Board of Directors
  • About GMO
    • ESG Capabilities
    • Our Clients
    • Our Approach
    • News and Media
  • ESG Investing
    • Stewardship
    • Industry Leadership and Collaboration
    • GMO | ESG Team
  • Solutions
    • ETF Investing at GMO
    • Quality Equity
    • Asset Allocation
    • Multi-Sector Fixed Income
    • Needs-Based Optimization - Nebo Wealth
  • Consultants
  • Intermediaries & Wealth Managers
  • Family Offices
  • Institutions
  • Document Library
  • How to Invest Asia
  • Log In_expired
  • Register
  • Reset Password
  • Create Password
  • Forgot Password
  • Subscribe
  • Contact QIFs & Private Funds
  • Contact
  • For the Media
  • Search Results
  • Sitemap
  • Privacy Notice
  • Benchmark Disclaimers
  • Terms and Conditions
  • Legal and Compliance
  • Web Fraud and Phishing Warning
  • Careers
  • U.S. Tax Forms 8937
  • 401
  • 404
  • 500
  • Press Releases
    • GMO Launches GMO Beyond China ETF (NYSE: BCHI) Focused on Global Supply Chain Shifts
    • GMO Expands ETF Lineup with New ETFs Focused on Value, International Quality
    • GMO U.S. Quality ETF (QLTY) Surpasses $1 Billion in Assets Under Management
    • GMO Launches Its First ETF, the Actively Managed GMO U.S. Quality ETF (NYSE: QLTY)
    • GMO’s Nebo Surpasses $1Billion in Platform Assets One Year After Launch
    • GMO Announces Initial Net Zero Asset Targets
    • GMO Launches Nebo, an Innovative Asset Management Platform for RIAs
    • GMO Announces Senior Hire as Deborah Ng Joins Firm as Head of ESG & Sustainability
    • GMO Commits to Net Zero Asset Managers Initiative
    • GMO’s Commitment to Asia
    • GMO Climate Change Trust Launch
    • GMO Launches Quality Global Equities Trust for Australian Investors
    • GMO to Acquire Usonian Investments
    • GMO Adds Investment Capability and Expands Management Team
  • 2021 GMO Conference Sessions
    • Needs-Based Allocation
    • Forecasts & Portfolios
    • Japan Rising
    • The Engine Behind Equity Dislocation
    • Quality Investing for Greed and Fear
    • China | Reading the Xi Leaves
    • Compound Returns
    • ESG Panel
    • The Practical Implications of Incorporating ESG into Systematic Global Macro
    • Real Assets: Pockets of Value in an Expensive World
    • Adding Yield without Sacrificing Defensiveness with Quality EM Debt
    • Sovereign Distressed Credit
    • Growth Traps and Value Opportunities
    • Risk and Reward in Commercial and Residential Real Estate Debt
    • Inflation
    • Rates and States
  • Distribution Estimates
  • Unsubscribe
  • Password Reset Link
  • Shades of 2000_Ben Inker
  • Mutual Fund Documents
  • ETF Documents
  • GMO Required Reading
  • Placeholder Content to be Updated
    • User Not Accredited Page
    • Mission and Values
    • History
  • CCS Exclusion List
  • Two-Factor Authentication
  • Log In
  • Nebo_Investing for retirement
  • GRRUF Exclusion List
  • PRIIPs Performance
  • PRIIPs Complaints
  • 2023 London Conference
  • 2024 London Conference
  • 2022 Year-End Letters
  • 2023 Year-End Letters
  • 2024 Year-End Letters
  • Equity Dislocation Strategy Video_Mandarin CC
  • SPS ESG & Sustainable Asset Strategies for Pension Funds
  • GMO High Yield Strategy
  • Industry Determination Methodology
  • QLTY - GMO U.S. Quality ETF
  • Quality: The Real McCoy
  • Quality for the Long Term and Today
  • The Quality Anomaly
  • Scope 1 and Scope 2 account for only 18% of GHG Emissions
  • horizons-exclusion-list
  • GMO Horizons: Employing Green Revenues in the Pursuit of Net-Zero Objectives
  • ESG Integration in Emerging Debt Markets
  • GMO Horizons
  • Horizons Environmental Controversies
  • CC Exclusion Methodology
  • CC Carbon Emissions List
  • Sector Determination Methodology
  • Tailored Shareholder Report
  • Tailored Shareholder ETF Report
  • JPMorgan - GMO Product Portal
    • Quality
      • Quality Video Library
  • CellTrust Privacy Notice
  • Annual Tailored Shareholder Report